Bluejay Diagnostics (BJDX) Shares Outstanding (Diluted Average) (2021 - 2026)

Bluejay Diagnostics' Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $984668.0 for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 610.94% year-over-year to $984668.0; the TTM figure through Mar 2026 stood at $984668.0 (up 610.94% YoY), while the FY2025 annual figure was $449043.0, up 879.42% from the prior year.
• Shares Outstanding (Diluted Average) came in at $984668.0 for Q1 2026 at Bluejay Diagnostics, up from $449043.0 in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $20.1 million in Q1 2022 to a low of $2741.0 in Q4 2023.
• A 5-year average of $1.7 million and a median of $449043.0 in 2025 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) slumped 99.73% in 2023 and surged 9944.14% in 2025, its largest moves.
• Bluejay Diagnostics' Shares Outstanding (Diluted Average) stood at $1.0 million in 2022, then plunged by 99.73% to $2741.0 in 2023, then jumped by 1572.67% to $45848.0 in 2024, then surged by 879.42% to $449043.0 in 2025, then jumped by 119.28% to $984668.0 in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $984668.0, $449043.0, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison